Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP for Alveolar Bone Resorption in RME
NCT03028038Phase 1Completed
- Sponsor
- Damascus University
- Start
- Jul 2016
- Primary completion
- May 2017
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of autologous platelet-rich plasma in Alveolar bone resorption (2 arms), sponsored by Damascus University. Primary endpoints: Changes in buccal alveolar bone height loss at 3 months and Changes in buccal alveolar bone thickness reduction amount at 3 months. Started Jul 2016; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
Alveolar bone resorption
Beyond the preview
Go deeper on NCT03028038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03028038.